P3 Health Partners appoints Atul Kavthekar as CFO effective Dec 12, 2022; interim CFO compensation set

P3 Health Partners Inc.

Atul Kavthekar appointed CFO effective Dec 12, 2022; previously EVP/CFO at EyeCare Partners.
Kavthekar receives $450K base salary, $50K signing bonus, option for 600K shares vesting over 4 years.
Interim CFO Erin Darakjian receives $50K lump sum, option for 100K shares, bonus target increased to 50%.
Darakjian retains role as Chief Accounting Officer and principal accounting officer after Kavthekar starts.
Kavthekar entitled to six months' base salary severance if terminated without cause, subject to release.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Erin Darakjian

Chief Accounting Officer

PIII · P3 Health Partners Inc.

Effective: 2022-12-12
Successor: Atul Kavthekar
Filed: December 1, 2022, 6:59 PM ET

succeeding Ms. Darakjian in such role. Ms. Darakjian remains Chief Accounting Officer, Senior Vice President and principal accounting officer of the Company.

Appointed

Atul Kavthekar

Chief Financial Officer

PIII · P3 Health Partners Inc.

Effective: 2022-12-12
Filed: December 1, 2022, 6:59 PM ET

On November 27, 2022, the Board appointed Atul Kavthekar to serve as Chief Financial Officer of the Company, effective as of December 12, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.75

Erin Darakjian changed role as Chief Accounting Officer at P3 Health Partners Inc..

Role: Chief Accounting Officer

Exact text from the filing

succeeding Ms. Darakjian in such role. Ms. Darakjian remains Chief Accounting Officer, Senior Vice President and principal accounting officer of the Company.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Atul Kavthekar was appointed as Chief Financial Officer at P3 Health Partners Inc..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On November 27, 2022, the Board appointed Atul Kavthekar to serve as Chief Financial Officer of the Company, effective as of December 12, 2022.

View on SEC.gov

P3 Health Partners Inc. filing history →

Source: SEC EDGAR

accession 0001104659-22-123694

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.